Kiora Pharmaceuticals Inc Cash Flow Quality Index

Latest as of September 2025: -47.49x

Kiora Pharmaceuticals Inc cash flow quality index. Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Quality Index of -47.49x as of September 2025. Operating cash flow of $-1.27 Million is below net income of $26.81K, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Kiora Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-47.49x

Operating CF / Net Income

Operating Cash Flow

$-1.27 Million

USD

Net Income

$26.81K

USD

Data as of

Sep 2025

Most recent filing

Cash Flow Quality Index of Kiora Pharmaceuticals Inc (2024–2024)

Cash flow quality index of Kiora Pharmaceuticals Inc from 2024 to 2024. Historical Cash Flow Quality Index for Kiora Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Kiora Pharmaceuticals Inc (KPRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Kiora Pharmaceuticals Inc Cash Flow Quality Index by Year (2024–2024)

Kiora Pharmaceuticals Inc cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Kiora Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Kiora Pharmaceuticals Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2024	2.38x	$8.56 Million	$3.59 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.